OREANDA-NEWS. Pune, India: Advinus Therapeutics, the Tata-promoted pharmaceutical R&D company, announced today that it has achieved the first-year milestone in its research and development collaboration with Takeda Pharmaceutical Company. The achievement of the milestone underscores the success of the collaboration, and also provides validation of Advinus's capabilities in innovative drug discovery and Takeda's confidence in these capabilities. As a consequence, a payment of \\$3 million will be made by Takeda to Advinus to mark the achievement.

In October 2012, Advinus and Takeda announced a multi-year, multi-project collaboration in the area of drug discovery. In this collaboration, Advinus is responsible for carrying out all the research required to identify candidate molecules for clinical development in several therapeutic areas, while Takeda is responsible for the development and commercialisation of these candidates.

“Achievement of the rather challenging first-year milestone can be attributed to the truly collaborative nature of our relationship with Takeda, as well as Advinus's young talent's ability to solve complex problems with efficiency and speed,” said Kasim Mookhtiar, CSO of Advinus.